Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.
Gulikers J, Bruinsma J, Schoenmaekers J, Dursun S, Tjan-Heijnen V, van Geel R, Croes S, Hendriks L. Gulikers J, et al. Among authors: croes s. Ther Adv Med Oncol. 2024 Dec 7;16:17588359241303403. doi: 10.1177/17588359241303403. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39649018 Free PMC article.
Sex and Common Germline Variants Affect the Toxicity Profile and Pharmacokinetics of Alectinib: A Nationwide Cohort Study in Patients With ALK-Positive NSCLC.
Heersche N, Lanser DAC, Muntinghe-Wagenaar MB, Mohmaed Ali MI, Ulas EB, Trooster TMA, de Jonge E, Oomen-de Hoop E, Paats MS, Bahce I, Croes S, Hendriks LEL, van der Wekken AJ, Dingemans AC, Huitema ADR, van Schaik RHN, Mathijssen RHJ, Veerman GDM. Heersche N, et al. Among authors: croes s. J Thorac Oncol. 2024 Nov 29:S1556-0864(24)02488-2. doi: 10.1016/j.jtho.2024.11.025. Online ahead of print. J Thorac Oncol. 2024. PMID: 39617342 Free article.
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.
Moes DJAR, Hendrikx JJMA, Guchelaar HJ, Mathijssen RHJ, Bakker JL, Dezentjé VO, de Rouw N, van Erp NP, Smit EF, van den Heuvel MM, Munnink THO, van Kats M, Croes S, Kroep JR, Zwaveling J, Ter Heine R. Moes DJAR, et al. Among authors: croes s. Target Oncol. 2024 Sep;19(5):789-796. doi: 10.1007/s11523-024-01075-8. Epub 2024 Jun 18. Target Oncol. 2024. PMID: 38890221 Free PMC article.
67 results